勇敢之心生物 BRVE
$18.60 +$1.19 (+6.80%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $18.60 0.00%
开盘$17.55
昨收$17.42
当日区间$16.89 – $18.99
成交量702.1K
市值$1.67B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$0.00
营业利润-$15.88M-58,722.2% YoY
净利润-$14.99M-3,833.9% YoY
摊薄每股收益-$0.30-3,290.6% YoY
自由现金流-$16.94M
经营现金流-$16.95M
营收，近4个季度
净利润，近4个季度
各季度摊薄每股收益
各季度自由现金流
盈利能力与资产负债表
资产收益率-77.6%
流动比率13.63
负债/资产比率175.5%
现金及投资$122.83M
总负债$198,000.00
净现金（净负债）$122.63M
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL |
|---|---|---|---|
| 留存收益 | -$95.91M | -$80.33M | -$66.05M |
| 股东权益 | -$95.91M | -$78.39M | -$65.87M |
| 股本 | $1,000.00 | $1,000.00 | $1,000.00 |
| 总资产 | $126.96M | $81.88M | $89.35M |
| 流动资产合计 | $123.45M | $81.07M | $89.28M |
| 现金及现金等价物与短期投资 | $122.83M | $80.58M | $89.16M |
| 其他流动资产 | $614,000.00 | $496,000.00 | $119,000.00 |
| 非流动资产合计 | $3.51M | $806,000.00 | $70,000.00 |
| 固定资产净值 | $630,000.00 | $736,000.00 | – |
| -固定资产原值 | $630,000.00 | $736,000.00 | – |
| 一年以上递延资产 | $2.81M | – | – |
| 其他非流动资产 | $70,000.00 | $70,000.00 | $70,000.00 |
| 负债合计 | $222.86M | $160.27M | $155.22M |
| 资本公积 | $0.00 | $1.94M | $179,000.00 |
| -普通股 | $1,000.00 | $1,000.00 | $1,000.00 |
| 流动负债合计 | $9.06M | $10.00M | $5.24M |
| -现金及现金等价物 | $122.83M | $80.58M | $89.16M |
| 短期债务及融资租赁负债 | $377,000.00 | $373,000.00 | – |
| -一年内到期融资租赁负债 | $377,000.00 | $373,000.00 | – |
| 非流动负债合计 | $213.80M | $150.27M | $149.98M |
| 股东权益合计 | -$95.91M | -$78.39M | -$65.87M |
| 其他非流动负债 | $86,000.00 | $89,000.00 | $91,000.00 |
| 可转换优先证券 | $213.52M | $149.89M | $149.89M |
| -长期融资租赁负债 | $198,000.00 | $294,000.00 | – |
| 长期债务及融资租赁负债 | $198,000.00 | $294,000.00 | – |
| 应付款 | $2.67M | $7.74M | $1.06M |
| -应付账款 | $2.67M | $7.74M | $1.06M |
| 一年内应计费用 | $4.47M | $1.19M | $3.87M |
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 营业总收入 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| 特殊收益（费用） | $0.00 | $0.00 | -$62.24M | -$354,000.00 | -$94,000.00 |
| 持续经营利润 | -$14.99M | -$14.28M | -$66.05M | -$381,000.00 | -$99,000.00 |
| 营业费用 | $15.88M | $15.05M | $4.51M | $27,000.00 | $5,000.00 |
| 销售及管理费用 | $4.76M | $4.14M | $3.02M | $27,000.00 | $5,000.00 |
| 摊薄每股收益 | -$0.30 | -$0.33 | -$5.32 | -$0.01 | -$0.00 |
| 基本每股收益 | -$0.30 | -$0.33 | -$5.32 | -$0.01 | -$0.00 |
| 归属普通股股东净利润 | -$18.60M | -$14.28M | -$66.05M | -$381,000.00 | -$99,000.00 |
| 优先股股息 | $3.62M | – | – | – | – |
| 归属母公司净利润 | -$14.99M | -$14.28M | -$66.05M | -$381,000.00 | -$99,000.00 |
| 净利润 | -$14.99M | -$14.28M | -$66.05M | -$381,000.00 | -$99,000.00 |
| 税前利润 | -$14.99M | -$14.28M | -$66.05M | -$381,000.00 | -$99,000.00 |
| 其他非经营性收入（支出） | $5,000.00 | -$2,000.00 | $1,000.00 | – | – |
| 其他收入（支出） | $5,000.00 | -$2,000.00 | -$62.24M | -$354,000.00 | -$94,000.00 |
| 非经营性利息收入 | $889,000.00 | $771,000.00 | $696,000.00 | $0.00 | $0.00 |
| 非经营性利息净收入（支出） | $889,000.00 | $771,000.00 | $696,000.00 | $0.00 | $0.00 |
| 营业利润 | -$15.88M | -$15.05M | -$4.51M | -$27,000.00 | -$5,000.00 |
| 研发费用 | $11.13M | $10.91M | $1.49M | $0.00 | $0.00 |
| -管理费用 | $4.76M | $4.14M | $3.02M | $27,000.00 | $5,000.00 |
| -减：其他特殊支出 | – | – | $62.24M | $354,000.00 | $94,000.00 |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q2 | 2025 Q1 |
|---|---|---|---|---|---|
| 筹资活动现金流 | $59.20M | -$363,000.00 | $124.74M | $2,000.00 | $0.00 |
| 自由现金流 | -$16.94M | -$8.22M | -$35.58M | $0.00 | $0.00 |
| 期初现金余额 | $80.58M | $89.16M | $0.00 | $0.00 | $0.00 |
| 现金净变动 | $42.26M | -$8.59M | $89.16M | – | – |
| 期末现金余额 | $122.83M | $80.58M | $89.16M | $2,000.00 | $0.00 |
| 持续经营筹资活动现金流净额 | $59.20M | -$363,000.00 | $124.74M | $2,000.00 | $0.00 |
| 无形资产购置及出售净额 | $0.00 | -$3.00M | -$33.57M | $0.00 | $0.00 |
| 其他筹资费用净额 | -$399,000.00 | -$363,000.00 | – | – | – |
| 固定资产购置及出售净额 | $8,000.00 | -$36,000.00 | – | $0.00 | $0.00 |
| -应付账款及应计费用变动 | -$2.93M | $7.78M | $1.81M | $33,000.00 | $7,000.00 |
| 投资活动现金流净额 | $8,000.00 | -$3.04M | -$33.57M | $0.00 | $0.00 |
| -预付资产变动 | -$120,000.00 | -$342,000.00 | -$119,000.00 | -$6,000.00 | -$2,000.00 |
| 持续经营投资活动现金流净额 | $8,000.00 | -$3.04M | -$33.57M | $0.00 | $0.00 |
| 营运资金变动 | -$3.05M | $7.33M | $1.62M | $27,000.00 | $5,000.00 |
| 折旧、折耗与摊销 | $3,000.00 | $2,000.00 | – | $0.00 | $0.00 |
| 持续经营净利润 | -$14.99M | -$14.28M | -$66.05M | -$381,000.00 | -$99,000.00 |
| 持续经营经营活动现金流净额 | -$16.95M | -$5.19M | -$2.01M | $0.00 | $0.00 |
| 经营活动现金流 | -$16.95M | -$5.19M | -$2.01M | $0.00 | $0.00 |
| -其他营运资金变动 | $0.00 | -$105,000.00 | – | – | – |
| -其他流动资产变动 | – | – | -$70,000.00 | – | – |
| 其他非现金项目 | – | – | $62.24M | $354,000.00 | $94,000.00 |
| 优先股发行净额 | – | – | $124.65M | – | – |
| 普通股发行净额 | – | – | $95,000.00 | – | – |
暂无评论——快来第一个聊聊 BRVE。